Cambrex Invests $24 Million in New Highly Potent API Manufacturing Capacity at Its Charles City, Iowa Facility
August 08, 2017 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Reports Second Quarter 2017 Financial Results
August 04, 2017 06:45 ET
|
Cambrex Corporation
- Net Revenue increased 13% and EBITDA increased 16% vs. prior year quarter - - 2017 full year financial guidance for Adjusted EBITDA and free cash flow increased - - Conference call at 8:30 a.m. ET...
Cambrex to Announce Second Quarter 2017 Financial Results on August 4, 2017
July 31, 2017 13:41 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., July 31, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 14:50 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., May 31, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today...
Cambrex to Present at the 2017 UBS Global Healthcare Conference
May 15, 2017 14:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., May 15, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today...
Cambrex Reports First Quarter 2017 Financial Results
May 04, 2017 06:40 ET
|
Cambrex Corporation
- Net Revenue increased 11% and EBITDA increased 26% vs. prior year quarter - - 2017 full year financial guidance reaffirmed - - Conference call at 8:30 a.m. ET on May 4, 2017 - EAST RUTHERFORD,...
Cambrex to Announce First Quarter 2017 Financial Results on May 4, 2017
May 01, 2017 15:50 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., May 01, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today...
Cambrex to Present at the 2017 RBC Capital Markets Global Healthcare Conference
February 15, 2017 10:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Reports Fourth Quarter and Full Year 2016 Financial Results
February 03, 2017 06:45 ET
|
Cambrex Corporation
- Gross Sales increased 14% in the fourth quarter and 13% for the full year 2016 - - 2017 Net Revenues expected to grow between 7% and 11% - - Conference call at 8:30 a.m. ET on February 3, 2017 - ...
Cambrex to Announce Fourth Quarter and Full Year 2016 Financial Results on February 3, 2017
February 01, 2017 07:35 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Feb. 01, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...